# US 2008/0188516 A1 · Imiadazo[4,5-c] pyridine compound and method of antiviral treatment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188516 A1
- Document ID: US20080188516A1
- Status: Published application
- Kind: A1
- Application number: 12/022,557
- Filed: 2008-01-30
- Published: 2008-08-07
- Earliest claimed: 2004-12-21
- Assignees: Gilead Sciences, Inc.; K.U. Leuven Research & Development; Gerhard Puerstinger
- Inventors: Steven S. BONDY; David A. Oare; Winston C. Tse
- Web page: https://patentgrep.com/patent/US20080188516A1

## CPC

- C07D 471/04: Ortho-condensed systems
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/12: Antivirals
- A61P 31/14: for RNA viruses
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The compound 5-((3-(2,4-trifluoromethyphenyl)isoxazol-5-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine, together with the salts and solvates thereof. Also provided are compositions comprising this compound and pharmaceutically acceptable carriers, as well as the use of such compositions in the treatment or prophylaxis of viral infections.

## Claims

### Claim 1

5-((3-(2,4-trifluoromethyphenyl)isoxazol-5-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine, and its salts and solvates.

### Claim 2 (depends on 1)

A composition comprising the compound of claim 1 and at least one pharmaceutically acceptable carrier.

### Claim 3 (depends on 1)

A method for treatment or prophylaxis of a viral infection comprising administering to a subject an antiviral amount of a compound of claim 1.

### Claim 4 (depends on 3)

The method of claim 3 wherein the viral infection is HCV.

### Claim 5 (depends on 1)

The compound of claim 1 as the free base.
